Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
2-[[(2S)-1-(2-phenylacetyl)prolyl]amino]acetic acid ethyl ester
Noopept is a synthetic nootropic that is primarily investigated for its potentially neuroprotective and cognitive-enhancing properties. It modulates glutamatergic receptors and may increase the expression of neurotrophic factors, which can contribute to the improvement of memory and learning ability. The substance is being studied in research regarding its effects on neurodegenerative diseases, with safety during intended use being assessed as relatively high.
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
Noopept acts through the following pharmacological mechanisms:
Designations
IUPAC: 2-[[(2S)-1-(2-phenylacetyl)prolyl]amino]acetic acid ethyl ester
Receptor Profile
Der NMDA-Rezeptor ist ein ionotroper Glutamatrezeptor, der eine zentrale Rolle bei synaptischer Plastizität, Lernen und Gedächtnisbildung spielt. Er benötigt sowohl Glutamat als auch Glycin als Co-Agonisten zur Aktivierung.
Der AMPA-Rezeptor ist ein ionotroper Glutamatrezeptor, der die schnelle exzitatorische synaptische Übertragung im ZNS vermittelt. Er arbeitet eng mit NMDA-Rezeptoren bei der synaptischen Plastizität zusammen.
Effects & Pharmacology — Translation in progress
This section is being translated. Content is available in German.
View in German →Total duration 4-6 hours
Peak
1-2 hours
Onset
30-60 minutes
Total duration
4-6 hours
After effects
2-4 hours
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, and pre-existing conditions significantly affect outcomes.
Risks
Summary
Langzeitwirkungen und Sicherheit sind nicht umfassend untersucht.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
May interact with other nootropics.
Possible interactions with psychotropic drugs.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.